165 related articles for article (PubMed ID: 19952950)
21. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
[TBL] [Abstract][Full Text] [Related]
22. [Tolerance and feasibility of adjuvant treatment of stage II malignant melanoma with high-dose interferon-alpha].
Bédane C; Le Brun V; Boulinguez S; Berdah JF; Bouyssou ML; Delpuget N; Bernard P; Tubiana-Mathieu N; Bonnetblanc JM
Ann Dermatol Venereol; 1999 Feb; 126(2):142-6. PubMed ID: 10352829
[TBL] [Abstract][Full Text] [Related]
23. The relationship between alexithymia and salivary cortisol levels in somatoform disorders.
Pedrosa Gil F; Bidlingmaier M; Ridout N; Scheidt CE; Caton S; Schoechlin C; Nickel M
Nord J Psychiatry; 2008; 62(5):366-73. PubMed ID: 18752108
[TBL] [Abstract][Full Text] [Related]
24. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
25. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
26. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome.
Strik JJ; Lousberg R; Cheriex EC; Honig A
J Psychosom Res; 2004 Jan; 56(1):59-66. PubMed ID: 14987965
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects.
Bannink M; Fekkes D; Van Gool AR; Kruit WH; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
Neuropsychobiology; 2007; 55(3-4):225-31. PubMed ID: 17873497
[TBL] [Abstract][Full Text] [Related]
28. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
[TBL] [Abstract][Full Text] [Related]
29. The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder.
Papatheodorou G; Kutcher S
J Psychiatry Neurosci; 1995 May; 20(3):226-32. PubMed ID: 7786884
[TBL] [Abstract][Full Text] [Related]
30. [Intensity of depression in pedagogy students].
Pietras T; Witusik A; Panek M; Zielińska-Wyderkiewicz E; Kuna P; Górski P
Pol Merkur Lekarski; 2012 Mar; 32(189):163-6. PubMed ID: 22568180
[TBL] [Abstract][Full Text] [Related]
31. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.
Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K
Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588
[TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.
Bannink M; Kruit WH; Van Gool AR; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
Psychosomatics; 2008; 49(1):56-63. PubMed ID: 18212177
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma.
Guillot B; Blazquez L; Bessis D; Dereure O; Guilhou JJ
Dermatology; 2004; 208(1):49-54. PubMed ID: 14730237
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes.
Greenberg DB; Jonasch E; Gadd MA; Ryan BF; Everett JR; Sober AJ; Mihm MA; Tanabe KK; Ott M; Haluska FG
Cancer; 2000 Jul; 89(2):356-62. PubMed ID: 10918166
[TBL] [Abstract][Full Text] [Related]
35. Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study.
Nevoralová Z; Dvořáková D
Int J Dermatol; 2013 Feb; 52(2):163-8. PubMed ID: 23347302
[TBL] [Abstract][Full Text] [Related]
36. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Capuron L; Gumnick JF; Musselman DL; Lawson DH; Reemsnyder A; Nemeroff CB; Miller AH
Neuropsychopharmacology; 2002 May; 26(5):643-52. PubMed ID: 11927189
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study.
Lieb K; Engelbrecht MA; Gut O; Fiebich BL; Bauer J; Janssen G; Schaefer M
Eur Psychiatry; 2006 Apr; 21(3):204-10. PubMed ID: 16632167
[TBL] [Abstract][Full Text] [Related]
38. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.
Capuron L; Ravaud A
N Engl J Med; 1999 Apr; 340(17):1370. PubMed ID: 10223879
[No Abstract] [Full Text] [Related]
39. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
[TBL] [Abstract][Full Text] [Related]
40. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C
Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
